After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Technique
February 24, 2023
(New York Times) – As Moderna racked up tens of billions of dollars in sales of its coronavirus vaccine, the company held off on paying for the rights to a chemical technique that scientists said it had borrowed from government-funded research and used in its wildly successful shot. But Moderna and the government have now reached an agreement. The company said on Thursday that it had made a $400 million payment for the technique that will be shared by the National Institutes of Health and two American universities where the method was invented. (Read More)